CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4- TETRAHYDROISOQUINOLINE AND USE THEREOF
9 Assignments
0 Petitions
Accused Products
Abstract
Novel [1,2,4]triazolo[1,5-a]pyridinyl-6-yl-substituted tetrahydroisoquinolines are described in the present invention. These compounds and crystalline forms SA1 and N-2 are used in the treatment of various neurological and physiological disorders. Methods of making these compounds and crystalline forms SA-1 and N-2 are also described in the present invention.
108 Citations
44 Claims
- 1. Crystalline Form SA-1 of
-
2. Crystalline Form SA-1 of
-
3. Crystalline Form SA-1 of
-
4. Crystalline Form SA-1 of
-
5. Crystalline Form SA-1 of
- 6. Substantially pure crystalline Form SA-1 of
- 22. Crystalline Form N-2 of
-
23. Crystalline Form N-2 of
-
24. Crystalline Form N-2 of
-
25. Crystalline Form N-2 of
-
26. Crystalline Form N-2 of
- 27. Substantially pure crystalline Form N-2 of
- 43. A process for preparation of a product compound of Formula (I)
Specification